Roche Group's total sales by division 2013-2024
Published by
In 2024, Roche's Pharmaceuticals division (the company’s larger segment) reported a sales value of 46.2 billion Swiss francs, while the Diagnostics division generated some 14.3 billion Swiss francs.
The Roche Group
The Roche Group, which is also known as F. Hoffmann-La Roche AG, is a Swiss-based pharmaceutical company with subsidiaries, such as Genetech, Spark Therapeutics, and Kapa Biosystems (Pty) Ltd. In 2024, the multinational enterprise generated 60.5 billion Swiss francs’ worth of total sales. Alongside each division, the Roche Group’s sales numbers have also been increasing recently, however, 2023 saw a significant decrease of around 4.5 billion francs. The company’s workforce included over 103,000 employees in 2024. The largest part of them were employed in Europe, while nearly 27,000 staff members were active in North America. Since 2011, Roche’s research and development expenditures have been increasing steadily, with a peak of over 15 billion Swiss francs in 2022 and 2024.
